CS Paper Radar

Toward an Agentic AI Approach to Public Health Data Collection

Xueyi Zhang, Hongru Du, Ensheng Dong

cs.MA ·submitted 2026-10-22 17:55 UTC · v1
benchmark

Abstract

Disease surveillance increasingly integrates automated data collection, yet predefined sources and procedures require manual adaptation as reporting practices change. We explore agentic artificial intelligence (AI) as an approach to coordinating surveillance data collection across heterogeneous sources. Specifically, we built a multi-agent framework that integrates source discovery, source assessment, evidence structuring, event linking, and validation. Three retrospective applications illustrate its promise. The workflow recovered all 13 individual cases in a hantavirus outbreak, with links to 85 distinct publisher domains compared with 28 in the reference benchmark, reconstructed Canadian measles counts with a final total 0.33% below the national reference and higher cumulative counts on 79.8% of comparable days, and increased the share of days with recent Sierra Leone mpox reports from 28.2% to 65.6% by incorporating attributed media. These demonstrations also reveal limitations in record completeness and accuracy, while prospective gains in timeliness remain untested. We envision agentic AI as a complementary layer of public health data infrastructure, coordinating evidence-linked collection under surveillance goals and standards defined by public health professionals.

Comment
46 pages, 2 figures; Supplementary Information included

Closest papers

Nearest neighbours by meaning across the whole index.

EpiGuard: An Autonomous Infectious-Disease Early Warning Agent Platform

cs.AI ·2026-10-14 ·Tonglong Wei, Zheng Yuan, Lingshuai Lin, Yuhui Yao, Xing Xie +1 more
similarity 0.71
Abstract

Infectious disease outbreaks often spread rapidly before signs of widespread transmission become apparent, leaving a big challenge for rapid response and effective intervention. However, current infectious-disease early-warning systems face three major challenges: fragmented epidemiological evidence across diverse surveillance sources, highly uneven data availability across diseases and geographic regions, and delayed warning procedure caused by manual data collection, analysis, and reporting. To address these challenges, we present EpiGuard, an autonomous, continually self-improving agentic platform for timely and reliable early warning of more than 50 infectious diseases across different regions. EpiGuard proactively monitors and captures newly released official surveillance records, using the latest available evidence for risk assessments. It dynamically adjusts its analytical strategy across three evidence availability regimes, enabling reliable risk assessment under diverse data conditions, ranging from the absence of historical observations to sparse and abundant evidence. Moreover, EpiGuard learns from the successful execution process by preserving effective data-acquisition and analytical procedures as reusable standard operating procedures, enabling it to progressively generalize to previously unseen diseases and regions. We use officially released infectious-disease surveillance data from the China CDC and the United States CDC to evaluate EpiGuard's effectiveness. Experimental results demonstrate that EpiGuard outperforms state-of-the-art forecasting systems, improving forecasting performance by 9.68% and 14.04% on the China CDC and U.S. CDC datasets, respectively.

0.20

AI-Driven Reproducibility and Analytical Robustness in Scientific Discovery

cs.AI cs.CL ·2026-10-16 ·Shicheng Liu, Krista Opsahl-Ong, Andrew Drozdov, Julian Killingback, Arnav Singhvi +4 more
benchmark similarity 0.68
Abstract

Reproducible and analytically robust research findings are essential to scientific progress, but evaluating these properties typically requires costly manual effort. We investigate whether LLM agents can help automate reproduction and robustness analysis, using a medical case study grounded in the Surveillance, Epidemiology, and End Results (SEER) database, a widely used U.S. cancer registry underlying tens of thousands of published studies. First, we introduce SEER-Repro, a benchmark of 20 published SEER-based papers together with the data and resources required to reproduce their findings. Second, we create an AI agent that successfully reproduces 77.4% of 2,190 atomic claims, while providing executable baselines for further analysis. Third, we develop an agentic analysis pipeline to test the robustness of the medical findings by identifying analytical choices underlying each finding, proposing defensible alternatives, and rerunning the analysis to determine whether those choices affect the conclusion. Across published papers in SEER-Repro, our pipeline identifies potentially consequential analytical choices in 9.5% of fully reproduced findings and flags them for expert review. These results show how LLM agents can support scientific review by reproducing findings, systematically testing their robustness, and directing expert attention toward potentially consequential analytical choices.

0.22

Research with AI Agents: How Agentic Systems Are Changing Scientific Work

cs.CY ·2026-09-25 ·Johannes Lotz, Markus Wenzel
similarity 0.64
Abstract · 6 pages, 1 figure. English translation followed by the original German version. Submitted to Die Pathologie (Springer Medizin)

Background. Agentic AI systems independently decompose tasks such as literature search, data analysis, and programming into subtasks, search the web, access databases, and execute code. This allows them to perform digital research tasks at high speed. Objectives. Under what conditions does the use of agentic systems produce reliable efficiency gains, and which tasks remain with researchers? Materials and methods. Summary of current studies on literature searches, data analysis, software development, and clinical decision support. Results. For digital activities, work shifts from execution to steering and review. Efficiency gains are greatest when expected behavior can be formalized in advance and tested automatically. In complex agentic systems, recorded sequences of reasoning steps and tool calls can quickly become too extensive for human review. Furthermore, explanations generated by the model do not reliably reflect how an output was produced. One possible step toward more reliable systems is the validation of individual components. The limited reviewability extends beyond research itself; the review of scientific articles and grant proposals is also reaching capacity limits. In pathology, curated and annotated data, researchers' own analytical skills, and institutional exchange of experience are becoming increasingly important. Conclusions. Researchers remain responsible for their results. They must determine what to delegate and how to review the results. The importance of a research question to patients, the field, and society cannot be fully assessed using formalized criteria and remains a matter of expert judgment. Agentic systems can free up time for this.

0.09

Universal Infectious Disease Forecasting with Mantis 2

cs.AI q-bio.PE ·2026-11-12 ·Carson Dudley, Reiden Magdaleno, Yutong Bi, Anthony Valencia, Xiaofeng Liu +1 more
similarity 0.64
Abstract

Public health agencies need to anticipate how outbreaks will unfold, when they will peak, and how long demand on health services will remain elevated. We previously developed a foundation model, Mantis, which was trained entirely on simulated outbreaks---enabling us to generate the diversity and scale of training data needed to support forecasting across diseases. However, our previous work left unresolved when simulation improves predictions and how it should complement observational data. Here, we varied the balance of simulated and observed training data while holding forecasting tasks fixed and varying the available surveillance history. We found that simulation-rich training was particularly valuable with limited local history, and its relative advantage diminished as more observations became available. We also found that simulation-based training reduced exceptionally large forecast errors, suggesting that mechanistic knowledge can help compensate for limited local evidence. Building on these findings, we developed Mantis 2, which combines simulated and observational training to jointly forecast up to six variables sixteen weeks ahead. Across 30 forecasting tasks, Mantis 2 achieved the best aggregate probabilistic accuracy over short, medium, and long horizons among the machine learning, statistical, and baseline models evaluated. It missed roughly 30\% fewer outbreak peaks than the strongest comparison model, with successfully anticipated peaks identified more than six weeks in advance on average. We publicly release Mantis 2, enabling public health agencies and researchers to forecast disease outcomes without developing a separate model for each disease or location.

0.26

BioStudyBench: Evaluating Agents on Post-Cutoff Biomedical Studies

cs.AI ·2026-10-06 ·David Li, Shaamil Karim, Christian Gensbigler
publishedbenchmark similarity 0.63
Abstract · Accepted into AgenticLS (NeurIPS 2026 workshop)

We evaluate whether AI agents can match the reported findings of published biomedical studies using public data. Existing evaluations do not consistently separate analysis from prior knowledge or retrieval of the published answer. We introduce BioStudyBench, a benchmark of 25 long-horizon analysis tasks drawn from studies first published between July and September 2026, after the developer-reported knowledge cutoffs of the models we evaluate, semi-automatically filtered down from 404,019 PubMed records. In each task, the agent receives a neutral research question but no data files, so it must find and download the relevant public data, search the literature through tools that return only records dated before its cutoff, and report findings through data analysis. To measure gains over prior knowledge, we run every task both with and without access to data and tools. Across eight models, access to data and tools raises the pass rate by 47 percentage points on average over the no-data baseline. Open-weight models across sizes trail closed-weight models, with the best open-weight model passing 81.3% of tasks against 94.7% for the best closed-weight model.

0.25

Driving Epidemic Models with AI Agents: the Epydemix Agent Framework

cs.AI cs.CY ·2026-09-23 ·Nicolò Gozzi, Ciro Cattuto, Alessandro Vespignani
code/data similarity 0.63
Abstract

Artificial Intelligence agents based on large language models provide convenient natural language interfaces to scientific software, but reliability is not automatic. Here we introduce the Epydemix Agent Framework, an additive layer over Epydemix, an open-source Python library for stochastic compartmental epidemic modeling. The framework extends the library with four capabilities to facilitate interaction with an AI agent: discovery of available models and parameters, preventive validation of a declarative scenario specification, execution through tested library code, and inspectability of results. These capabilities let an agent handle the entire modeling process, from the natural-language description of the scenario to quantitative results, figures, and interpretation of findings without writing custom code. Each step reads input files and saves results in a separate output bundle, making the process auditable and reproducible. First, we show the end-to-end workflow with a case study comparing vaccination strategies for a novel respiratory virus. Second, we assessed the framework across 50 agent sessions and five modeling tasks by comparing the agent use of the framework against the direct use of the Python interface. The framework reduced turns, output tokens, and cost on most tasks, unless it trades resources for per-point reproducibility.

0.26

MedCaseAgent: From Multimodal Clinical Evidence to Rare Disease Case Reports

cs.AI ·2026-10-23 ·Hongkang Chu, Yifan Shen, Tianjiao Yu, Zhuoqing Zhong, Jianguo Cao +2 more
code/data similarity 0.63
Abstract

Although Large Language Models (LLMs) have demonstrated potential in clinical documentation, generating the rigorous, evidence-based reasoning required for unprecedented, atypical, and rare disease case reports remains a significant challenge. We present MedCaseAgent, an end-to-end agentic reasoning paradigm that bridges this gap by synthesizing publication-quality reports from unstructured clinical notes. MedCaseAgent leverages a hierarchical structure, integrating patient-level data mining with iterative, tool-integrated reasoning. By dynamically querying medical literature and knowledge bases, the agent maintains high clinical fidelity and assesses case novelty. The framework is inherently modular, supporting various backbone LLMs in a plug-and-play fashion. To facilitate this research, we release MedCase-150K, a large-scale multimodal clinical case-report corpus, and MedCase-Bench, a robust temporally held-out evaluation suite. We also introduce an open-source model post-trained from Qwen3.5-9B and optimized specifically for this task. Under both LLM-judged and rule-based evaluation, MedCaseAgent outperforms existing general-purpose and specialized medical LLMs and agents. Blinded expert reviews and ablations further support the system's clinical relevance and evidence grounding.

0.25

Can AI Agents Interface Clinicians and Complex Models?

cs.MA cs.AI ·2026-10-29 ·Giulio Colombini, Matteo Falcioni, Mario Massimo, Francesco Durazzi, Marianna Santoro +3 more
similarity 0.61
Abstract · 21 pages, 7 figures

Background: Contemporary healthcare institutions generate daily very large amounts of data, which contain highly useful information for the improvement of work organization, planning and overall efficiency. While models and techniques to extract these insights are well known and constantly developed in mathematical biology, complex systems physics and data science, the adoption of these techniques among Clinicians and Hospital Administrators remains limited, mainly due to language and methodological divides. Objective: In this article we implement an AI Multi Agent System (MAS) that allows Users to use predictive models and make statistical analyses via natural language conversations. Methods: We developed EpidemIA, a training-free MAS endowed with a modular suite of epidemiological models written by human experts, executable on a single-GPU workstation. To avoid relaying sensitive data to third parties, the system uses locally an open-weights LLM as backbone for its two subagents. Results: Using a dataset of Emergency Department visits provided to us by IRCCS Sant'Orsola (Bologna) we test the model on a few typical use cases, demonstrating the possibility of performing both simpler statistical analyses and visualizations as well as more complicated epidemiological predictions based on dynamical models, through simple queries made in natural language. Conclusions: While still being a proof-of-concept implementation, EpidemIA showcases the transformative capabilities of LLM based technologies as an enabling factor in the widespread adoption of complex dynamical models, which is at present hindered by their steep learning curve.

0.14